U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Lung adenocarcinoma

MedGen UID:
57744
Concept ID:
C0152013
Neoplastic Process
Synonyms: Adenocarcinoma of lung; Adenocarcinoma of lung, somatic
SNOMED CT: Adenocarcinoma of lung (254626006)
 
HPO: HP:0030078
Monarch Initiative: MONDO:0005061
OMIM®: 211980
Orphanet: ORPHA415268

Definition

A carcinoma that arises from the lung and is characterized by the presence of malignant glandular epithelial cells. There is a male predilection with a male to female ratio of 2:1. Usually lung adenocarcinoma is asymptomatic and is identified through screening studies or as an incidental radiologic finding. If clinical symptoms are present they include shortness of breath, cough, hemoptysis, chest pain, and fever. Tobacco smoke is a known risk factor. [from NCI]

Conditions with this feature

Lung cancer
MedGen UID:
66885
Concept ID:
C0242379
Neoplastic Process
A primary or metastatic malignant neoplasm involving the lung.
Li-Fraumeni syndrome 1
MedGen UID:
322656
Concept ID:
C1835398
Disease or Syndrome
Li-Fraumeni syndrome (LFS) is a cancer predisposition syndrome associated with high risks for a diverse spectrum of childhood- and adult-onset malignancies. The lifetime risk of cancer in individuals with LFS is =70% for men and =90% for women. Five cancer types account for the majority of LFS tumors: adrenocortical carcinomas, breast cancer, central nervous system tumors, osteosarcomas, and soft-tissue sarcomas. LFS is associated with an increased risk of several additional cancers including leukemia, lymphoma, gastrointestinal cancers, cancers of head and neck, kidney, larynx, lung, skin (e.g., melanoma), ovary, pancreas, prostate, testis, and thyroid. Individuals with LFS are at increased risk for cancer in childhood and young adulthood; survivors are at increased risk for multiple primary cancers.
BAP1-related tumor predisposition syndrome
MedGen UID:
482122
Concept ID:
C3280492
Disease or Syndrome
BAP1 tumor predisposition syndrome (BAP1-TPDS) is associated with an increased risk for a specific skin lesion, BAP1-inactivated melanocytic tumors (BIMT; formerly called atypical Spitz tumors), and the following cancers, in descending order of frequency: uveal (eye) melanoma (UM), malignant mesothelioma (MMe), cutaneous melanoma (CM), renal cell carcinoma (RCC), and basal cell carcinoma (BCC). Hepatocellular carcinoma, cholangiocarcinoma, and meningioma may also be associated with BAP1-TPDS. Affected individuals can have more than one type of primary cancer. In general, the median age of onset of these tumors is younger than in the general population. UM tends to be a more aggressive class 2 tumor with higher risk for metastasis and reduced survival compared to UM occurring in the general population. Due to the limited number of families reported to date, the penetrance, natural history, and frequencies of BAP1-associated tumors are yet to be determined. Other suspected but unconfirmed tumors in BAP1-TPDS include (in alphabetic order): breast cancer, neuroendocrine carcinoma, non-small-cell lung adenocarcinoma, thyroid cancer, and urinary bladder cancer.
Fanconi renotubular syndrome 5
MedGen UID:
1711127
Concept ID:
C5394473
Disease or Syndrome
Fanconi renotubular syndrome-5 (FRTS5) is a mitochondrial disorder characterized by proximal renotubular dysfunction from birth, followed by progressive kidney disease and pulmonary fibrosis. It occurs only in individuals of Acadian descent (Crocker et al., 1997 and Hartmannova et al., 2016). For a discussion of genetic heterogeneity of Fanconi renotubular syndrome, see FRTS1 (134600).

Professional guidelines

PubMed

Yin X, Li Y, Wang H, Jia T, Wang E, Luo Y, Wei Y, Qin Z, Ma X
Semin Cancer Biol 2022 Nov;86(Pt 2):595-606. Epub 2022 Mar 8 doi: 10.1016/j.semcancer.2022.03.006. PMID: 35276343
Rolfo C, Mack P, Scagliotti GV, Aggarwal C, Arcila ME, Barlesi F, Bivona T, Diehn M, Dive C, Dziadziuszko R, Leighl N, Malapelle U, Mok T, Peled N, Raez LE, Sequist L, Sholl L, Swanton C, Abbosh C, Tan D, Wakelee H, Wistuba I, Bunn R, Freeman-Daily J, Wynes M, Belani C, Mitsudomi T, Gandara D
J Thorac Oncol 2021 Oct;16(10):1647-1662. Epub 2021 Jul 8 doi: 10.1016/j.jtho.2021.06.017. PMID: 34246791
Denisenko TV, Budkevich IN, Zhivotovsky B
Cell Death Dis 2018 Jan 25;9(2):117. doi: 10.1038/s41419-017-0063-y. PMID: 29371589Free PMC Article

Curated

EGFR-TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer

Recent clinical studies

Etiology

Qi C, Ma J, Sun J, Wu X, Ding J
Aging (Albany NY) 2023 Jun 13;15(11):5075-5095. doi: 10.18632/aging.204782. PMID: 37315289Free PMC Article
Liu J, Shen H, Gu W, Zheng H, Wang Y, Ma G, Du J
Front Immunol 2022;13:960738. Epub 2022 Aug 11 doi: 10.3389/fimmu.2022.960738. PMID: 36032135Free PMC Article
Liu Z, Zhang K, Zhao Z, Qin Z, Tang H
Medicine (Baltimore) 2022 Jan 7;101(1):e28500. doi: 10.1097/MD.0000000000028500. PMID: 35029906Free PMC Article
Borczuk AC
Mod Pathol 2022 Jan;35(Suppl 1):28-35. Epub 2021 Oct 6 doi: 10.1038/s41379-021-00934-3. PMID: 34615984
Zengin T, Önal-Süzek T
BMC Bioinformatics 2020 Sep 30;21(Suppl 14):368. doi: 10.1186/s12859-020-03691-3. PMID: 32998690Free PMC Article

Diagnosis

Liu J, Shen H, Gu W, Zheng H, Wang Y, Ma G, Du J
Front Immunol 2022;13:960738. Epub 2022 Aug 11 doi: 10.3389/fimmu.2022.960738. PMID: 36032135Free PMC Article
Nguyen TT, Lee HS, Burt BM, Wu J, Zhang J, Amos CI, Cheng C
Genome Med 2022 Jan 12;14(1):5. doi: 10.1186/s13073-021-01010-w. PMID: 35016696Free PMC Article
Zengin T, Önal-Süzek T
BMC Bioinformatics 2020 Sep 30;21(Suppl 14):368. doi: 10.1186/s12859-020-03691-3. PMID: 32998690Free PMC Article
Hutchinson BD, Shroff GS, Truong MT, Ko JP
Semin Ultrasound CT MR 2019 Jun;40(3):255-264. Epub 2018 Nov 30 doi: 10.1053/j.sult.2018.11.009. PMID: 31200873
Pascoe HM, Knipe HC, Pascoe D, Heinze SB
J Med Imaging Radiat Oncol 2018 Oct;62(5):654-661. Epub 2018 Aug 6 doi: 10.1111/1754-9485.12779. PMID: 30079974

Therapy

Luo MY, Zhou Y, Gu WM, Wang C, Shen NX, Dong JK, Lei HM, Tang YB, Liang Q, Zou JH, Xu L, Ma P, Zhuang G, Bi L, Xu L, Zhu L, Chen HZ, Shen Y
Cancer Res 2022 Oct 4;82(19):3516-3531. doi: 10.1158/0008-5472.CAN-21-4074. PMID: 36193649
Sun GZ, Zhao TW
Math Biosci Eng 2019 Oct 28;17(1):737-746. doi: 10.3934/mbe.2020038. PMID: 31731374
Skoulidis F, Goldberg ME, Greenawalt DM, Hellmann MD, Awad MM, Gainor JF, Schrock AB, Hartmaier RJ, Trabucco SE, Gay L, Ali SM, Elvin JA, Singal G, Ross JS, Fabrizio D, Szabo PM, Chang H, Sasson A, Srinivasan S, Kirov S, Szustakowski J, Vitazka P, Edwards R, Bufill JA, Sharma N, Ou SI, Peled N, Spigel DR, Rizvi H, Aguilar EJ, Carter BW, Erasmus J, Halpenny DF, Plodkowski AJ, Long NM, Nishino M, Denning WL, Galan-Cobo A, Hamdi H, Hirz T, Tong P, Wang J, Rodriguez-Canales J, Villalobos PA, Parra ER, Kalhor N, Sholl LM, Sauter JL, Jungbluth AA, Mino-Kenudson M, Azimi R, Elamin YY, Zhang J, Leonardi GC, Jiang F, Wong KK, Lee JJ, Papadimitrakopoulou VA, Wistuba II, Miller VA, Frampton GM, Wolchok JD, Shaw AT, Jänne PA, Stephens PJ, Rudin CM, Geese WJ, Albacker LA, Heymach JV
Cancer Discov 2018 Jul;8(7):822-835. Epub 2018 May 17 doi: 10.1158/2159-8290.CD-18-0099. PMID: 29773717Free PMC Article
Dong ZY, Zhong WZ, Zhang XC, Su J, Xie Z, Liu SY, Tu HY, Chen HJ, Sun YL, Zhou Q, Yang JJ, Yang XN, Lin JX, Yan HH, Zhai HR, Yan LX, Liao RQ, Wu SP, Wu YL
Clin Cancer Res 2017 Jun 15;23(12):3012-3024. Epub 2016 Dec 30 doi: 10.1158/1078-0432.CCR-16-2554. PMID: 28039262
Paez JG, Jänne PA, Lee JC, Tracy S, Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, Naoki K, Sasaki H, Fujii Y, Eck MJ, Sellers WR, Johnson BE, Meyerson M
Science 2004 Jun 4;304(5676):1497-500. Epub 2004 Apr 29 doi: 10.1126/science.1099314. PMID: 15118125

Prognosis

Liu Z, Zhang K, Zhao Z, Qin Z, Tang H
Medicine (Baltimore) 2022 Jan 7;101(1):e28500. doi: 10.1097/MD.0000000000028500. PMID: 35029906Free PMC Article
Shi R, Bao X, Unger K, Sun J, Lu S, Manapov F, Wang X, Belka C, Li M
Theranostics 2021;11(10):5061-5076. Epub 2021 Mar 5 doi: 10.7150/thno.56202. PMID: 33754044Free PMC Article
Wang Y, Zhou Z, Chen L, Li Y, Zhou Z, Chu X
Mol Cell Biochem 2021 Feb;476(2):931-939. Epub 2020 Nov 1 doi: 10.1007/s11010-020-03959-5. PMID: 33130972
Zengin T, Önal-Süzek T
BMC Bioinformatics 2020 Sep 30;21(Suppl 14):368. doi: 10.1186/s12859-020-03691-3. PMID: 32998690Free PMC Article
Cagney DN, Martin AM, Catalano PJ, Redig AJ, Lin NU, Lee EQ, Wen PY, Dunn IF, Bi WL, Weiss SE, Haas-Kogan DA, Alexander BM, Aizer AA
Neuro Oncol 2017 Oct 19;19(11):1511-1521. doi: 10.1093/neuonc/nox077. PMID: 28444227Free PMC Article

Clinical prediction guides

Zhang Z, Zhu H, Wang X, Lin S, Ruan C, Wang Q
Comput Biol Med 2023 Mar;154:106597. Epub 2023 Jan 24 doi: 10.1016/j.compbiomed.2023.106597. PMID: 36708655
Gu X, Huang X, Zhang X, Wang C
Int J Biol Sci 2022;18(13):4984-5000. Epub 2022 Aug 1 doi: 10.7150/ijbs.75284. PMID: 35982906Free PMC Article
Wu J, Li L, Zhang H, Zhao Y, Zhang H, Wu S, Xu B
Oncogene 2021 Jul;40(26):4413-4424. Epub 2021 Jun 9 doi: 10.1038/s41388-021-01853-y. PMID: 34108619
Ai D, Yao J, Yang F, Huo L, Chen H, Lu W, Soto LMS, Jiang M, Raso MG, Wang S, Bell D, Liu J, Wang H, Tan D, Torres-Cabala C, Gan Q, Wu Y, Albarracin C, Hung MC, Meric-Bernstam F, Wistuba II, Prieto VG, Sahin AA, Ding Q
Mod Pathol 2021 Apr;34(4):710-719. Epub 2020 Oct 3 doi: 10.1038/s41379-020-00692-8. PMID: 33011748
Liu Y, Ye G, Huang L, Zhang C, Sheng Y, Wu B, Han L, Wu C, Dong B, Qi Y
Aging (Albany NY) 2020 Nov 10;12(21):21559-21581. doi: 10.18632/aging.103945. PMID: 33170151Free PMC Article

Recent systematic reviews

Ebrahimi A, Derakhshan SM, Ghavi D, Foruzandeh Z, Hashemi S
Pathol Res Pract 2023 Sep;249:154576. Epub 2023 Jun 1 doi: 10.1016/j.prp.2023.154576. PMID: 37562284
Shen X, Li L, Zhang L, Liu W, Wu Y, Ma R
Int J Biol Markers 2022 Dec;37(4):377-385. Epub 2022 Jul 28 doi: 10.1177/03936155221115750. PMID: 35902998
Roca E, Gurizzan C, Amoroso V, Vermi W, Ferrari V, Berruti A
Cancer Treat Rev 2017 Sep;59:117-122. Epub 2017 Jul 31 doi: 10.1016/j.ctrv.2017.07.007. PMID: 28806542
Guo L, Liu S, Zhang S, Chen Q, Zhang M, Quan P, Sun X
Oncotarget 2017 May 23;8(21):34507-34515. doi: 10.18632/oncotarget.15671. PMID: 28427144Free PMC Article
Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ, Van Schil PE, Garg K, Austin JH, Asamura H, Rusch VW, Hirsch FR, Scagliotti G, Mitsudomi T, Huber RM, Ishikawa Y, Jett J, Sanchez-Cespedes M, Sculier JP, Takahashi T, Tsuboi M, Vansteenkiste J, Wistuba I, Yang PC, Aberle D, Brambilla C, Flieder D, Franklin W, Gazdar A, Gould M, Hasleton P, Henderson D, Johnson B, Johnson D, Kerr K, Kuriyama K, Lee JS, Miller VA, Petersen I, Roggli V, Rosell R, Saijo N, Thunnissen E, Tsao M, Yankelewitz D
J Thorac Oncol 2011 Feb;6(2):244-85. doi: 10.1097/JTO.0b013e318206a221. PMID: 21252716Free PMC Article

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Curated

    • NICE, 2013
      EGFR-TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...